The World Market for Prescription Cardiovascular Drugs
Posted on: Thursday, 8 November 2007, 06:00 CST
Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is available in its catalogue.
The World Market for Prescription Cardiovascular Drugs, 2nd Edition
To order that report:
www.reportlinker.com/p062949/PRBW-Prescription- Cardiovascular-Drugs.html
(Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
For more information, contact Nicolas by email nbo@reportlinker.com , or by phone +33 4 37 65 17 03.
Description
As one of the most competitive pharmaceutical markets, keeping track of the cardiovascular drug market can be a difficult undertaking. The range of therapeutic options available to physicians has expanded significantly in the past few years, and will continue to increase with a robust pipeline. This report is designed to steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments.
The following market segments are covered:
- Cardiac Glycosides and Positive Inotropic Agents
- Antihypertensive Agents (ACE Inhibitors, Angiotensin II Receptor Antagonists, Adrenergic Blockers, Beta Blockers, Calcium Channel Blockers, Combinations)
- Antiarrhythmic Agents (Class I, Class II, Class III)
- Vasodilators and Peripheral Vasodilator Agents
- Antihyperlipidemic Agents (Bile Acid Sequestrants, Fibric Acid Derivatives, Statins, Nicotonic Acid)
- Blood Moadifiers (Anticoagulants, Antiplatelets, Thrmbolytics)
- Diuretic Agents (Carbonic Anhydrase Inhibitors, Loop, Potassium-Sparing, Thiazides)
- Other Cardiovascular Agents
Specific diseases and disorders discussed include:
- Angina
- Arrhythmia
- Atherosclerosis
- Congestive heart failure
- Coronary artery disease
- Hypertension
- Myocardial infarction
- Other disorders
The report details the various categories of cardiovascular drugs and describes U.S. and non-U.S. markets in each of the specific cardiovascular drug areas. Revenues are considered in each subsegment according to type of drug. In addition, top products in each category are reviewed. The report also covers market drivers and trends that are influencing the market, including:
- Obesity Epidemic and Heart Disease
- Statin use
- Inflammation Reduction
- Unique Drug Combinations
- Hormone Therapy and Cardiovascular Disease Risks
- CAD Risk Factor Differences in Sexes
- Women and Heart Disease
- OTC Statins
- Genetic Research and Wafarin Use
- Future Trends in the Pharmaceutical Arena
The report further identifies major market factors, which are discussed in detail, and a total market summary is presented.
All market data are presented at the manufacturers' level. Data are expressed in current U.S. dollars. The base year for data was 2004. Historical data are provided for 2002 and 2003, and forecast data are provided for each of the years 2005 through 2009. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2004 base year.
Information and analysis presented in this report are based on extensive interviews with senior management of top companies and other participants in the cardiovascular market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals.
Key information from published literature was used to conduct interviews with over 41 industry executives and product managers to validate and obtain expert opinion on current and future trends in the cardiovascular market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.
Table of content
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: INTRODUCTION
* Overview of the Cardiovascular System
* Heart
* Circulatory System
* Cardiac Cycle
* Isovolumic Contraction
* Ventricular Ejection
* Isovolumic Relaxation
* Coronary Circulation
* Cardiac Myocytes
* Contraction
* Calcium Role in Contraction
* Relaxation
* Cardiac Energy Metabolism
* Cardiac Output
* Cardiovascular Disorders
* Angina
* Arrhythmias
* Atherosclerosis
* Congestive Heart Failure
* Coronary Artery Disease
* Hypertension
* Myocardial Infarction
* Effects of Aging
* Demographics
* Disease Management
CHAPTER THREE: ISSUES AND TRENDS
* Obesity Epidemic and Heart Disease
* Statin use
* Inflammation Reduction
* Unique Drug Combinations
* Hormone Therapy and Cardiovascular Disease Risks
* CAD Risk Factor Differences in Sexes
* Women and Heart Disease
* Otc Statins
* Genetic Research and Warfarin Use
* Future Trends in the Pharmaceutical Arena
CHAPTER FOUR: PRESCRIPTION CARDIAC GLYCOSIDE AND IONTROPIC DRUGS
* Overview of Cardiac Glycosides and Inotropic Drugs
* Description of Products
* Market Size and Growth World Market
* Research and Development
* Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIHYPERTENSIVE DRUGS
* Overview
* Description of Products
* ACE Inhibitors
* Angiotensin II Receptor Antagonists
* Adrenergic Blockers
* Beta Blockers
* Recent Additions
* Calcium Channel Blockers
* Combinations
* New Developments
* Market Size and Growth
* World Market
* Research and Development
o Nebivolol
o CS- 8663
o Volibris
o Atacand Plus
o Clevidipine
o Coreg CR Plus ACE Inhibitor
o Darusentan
* Competitive Analysis
CHAPTER SIX: PRESCRIPTION ANTIARRHYTHMIC DRUGS
* Overview
* Description of Products
* Market Size and Growth
* World Market
* Research and Development
o Tedasamil (Pulzium)
o RSD 1235 (vernakalant)
o Apixaban
o Bay 59-7939
o Dronedarone (Multaq)
o Idraparinux
o Tecadenoson
* Competitive Analysis
CHAPTER SEVEN: VASODILATOR AND PERIPHERAL VASODILATOR DRUGS
* Overview
* Description of Products
* Coronary Vasodilators
* Natriuretic Peptides
* Peripheral Vasodilators
* Recent Developments
* Market Size and Growth
* World Market
* Research and Development
o BiDil
o GeneRx
* Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION ANTIHYPERLIPIDEMIC DRUGS
* Overview
* Description of Products
* Market Size and Growth
* World Market
* Research and Development
o LCP-FenoChol
o Synordia
o Acomplia
o Actos
o MK 0524A, MK0524B
o Pravastatin and Fenofibrate Combination
o AGI-`067
o ABT-335
o Apo-I Milano (ETC-216)
o ETC-642
o FM-VP4
* Competitive Analysis
CHAPTER NINE: PRESCRIPTION BLOOD MODIFIER DRUGS
* Overview
* Description of Products
* New Developments
* Market Size and Growth
* World Market
* Research and Development
o Arixtra
o Exanta
o Cangrelor
o (Prasugrel) CS-747
o Integrilin
* Competitive Analysis
CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS
* Overview
* Description of Products
* Carbonic Anhydrase Inhibitors
* Loop
* Potassium-Sparing
* Thiazides
* Market Size and Growth
* World Market
* Research and Development
* Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS
* Overview
* Description of Products
* Market Size and Growth
* World Market
* Research and Development
* Thelin
* Remodulin IV
* Ambrisentan (Letairis)
* Celacade
* Tadalafil
* Tolvaptan
* DITPA
* Competitive Analysis
CHAPTER TWELVE: WORLD MARKET SUMMARY
* Overview
* Total Market Size and Forecast
* Competitor Analysis
CHAPTER THIRTEEN: CORPORATE PROFILES
* Abbott Laboratories
* AStellas Pharma, Inc.
* Astra Zeneca
* Bayer Schering Pharma
* Biovail Corporation
* Boehringer Ingelheim GmbH
* Bristol-Myers Squibb Company
* Daiichi Sankyo Pharmaceuticals
* Eli Lilly and Company
* Genentech, Inc.
* GlaxoSmithKline
* MERCK & COMPANY INC
* Novartis International AG
* Pfizer, Inc.
* Roche
* Sanofi-Aventis
* Takeda Pharmaceuticals
* Emerging Cardiovascular Companies
* Cardiome Pharma Corporation
* Inotek Pharmaceuticals Corporation
APPENDIX: COMPANY DIRECTORY
More market research reports? Go to http://www.reportlinker.com
http://market-research.typepad.com/agricultural_chemicals/
Source: Business Wire
Related Articles
- China Potassium Sulfate Market Study Research Report Provides Estimations and Analysis on China's Potassium Sulfate Market for 2007-2008
- Hard & Superhard Materials-World Markets, Technologies & Competition: 2007-2012 Analysis & Forecasts
- Research and Markets: 2006 Research Available on Alcatel, Cisco, and Siemens Other Carrier Ethernet Products
- Research and Markets: 2006 Research Available on Alcatel, Cisco, Alcatel, Ericsson and Other MultiService Switching Products
- Research and Markets: 2006 Research Available on ADTRAN, Alcatel, ECI Telecom, and Other Remote DSLAMs Products
- Research and Markets: 2006 Research Available on Alcatel, Ciena, Cisco, and Other Optical Switching Products
- Research and Markets: 2006 Research Available on Alcatel, Cisco, Siemens and Other Media Gateways Products
- Research and Markets: 2006 Research Available on Alcatel, Ciena, Ericsson and Other WAN DWDM Products
- Research and Markets: 2006 Research Available On Avici, Cisco, Juniper Networks and Other Core IP Routing Products
- All American Research and Drug Testing Launches Drug Screening Product
 |
 |
User Comments (0)
RSS Feeds